Simplex Trading’s Checkpoint Therapeutics CKPT Stock Holding History

Simplex Trading’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,611	Closed	-$27.2K	–	8927
2023 Q4	$31K	Buy	13,611 +11,459	+532%	+$24.9K	﹤0.01%	6527
2023 Q3	$3K	Buy	+2,152	New	+$4.89K	﹤0.01%	7867
2023 Q2	–	Sell	-8,327	Closed	-$22.7K	–	9061
2023 Q1	$18K	Buy	+8,327	New	+$41.8K	﹤0.01%	6997
2022 Q3	–	Sell	-5,064	Closed	-$60.3K	–	9987
2022 Q2	$52K	Buy	5,064 +2,176	+75%	+$28.5K	﹤0.01%	6433
2022 Q1	$51K	Sell	2,888 -7,859	-73%	-$169K	﹤0.01%	7093
2021 Q4	$334K	Buy	10,747 +9,501	+763%	+$315K	﹤0.01%	4388
2021 Q3	$36K	Hold	1,246	–	–	﹤0.01%	7905
2021 Q2	$36K	Buy	1,246 +1,036	+493%	+$28.7K	﹤0.01%	8021
2021 Q1	$6K	Buy	+210	New	+$7.04K	﹤0.01%	8130

Simplex Trading's CKPT Position: Q1 2024 in Review

Simplex Trading sold out of Checkpoint Therapeutics (CKPT) in Q1 2024, closing a stake of 13,611 shares — an estimated $27.2K sold.

Simplex Trading first reported a position in CKPT in Q1 2021 and held it in 9 quarters. The position peaked at $334K in Q4 2021. 40 funds tracked by Wall St. Rank hold CKPT as of Q1 2024.

Simplex Trading reported no remaining Checkpoint Therapeutics position as of Q1 2024 after selling out during the quarter.
Simplex Trading sold 13,611 Checkpoint Therapeutics shares in Q1 2024, an estimated $27.2K.
Simplex Trading first reported a position in Checkpoint Therapeutics in Q1 2021 and held it in 9 quarters.
Simplex Trading's Checkpoint Therapeutics position peaked at $334K in Q4 2021.
40 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.